Immunocore Holdings plc
IMCR
$28.22
-$0.30-1.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.63% | 24.30% | 29.22% | 29.93% | 33.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.63% | 24.30% | 29.22% | 29.93% | 33.16% |
| Cost of Revenue | -47.77% | -20.48% | 33.57% | 32.72% | 237.80% |
| Gross Profit | 14.18% | 21.83% | 20.64% | 23.41% | 32.44% |
| SG&A Expenses | -5.84% | 0.76% | 11.95% | 10.75% | 2.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -9.29% | -- | -- | -- |
| Total Operating Expenses | 1.95% | 22.22% | 24.92% | 23.43% | 0.52% |
| Operating Income | 301.33% | 102.64% | 15.66% | 7.13% | 86.35% |
| Income Before Tax | 118.15% | 36.37% | -95.01% | 4.30% | 125.27% |
| Income Tax Expenses | -71.63% | 1,458.67% | 118.20% | -59.22% | 197.20% |
| Earnings from Continuing Operations | 158.23% | -26.46% | -102.03% | 11.33% | 120.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 158.23% | -26.46% | -102.03% | 11.33% | 120.56% |
| EBIT | 301.33% | 102.64% | 15.66% | 7.13% | 86.35% |
| EBITDA | 397.90% | 470.64% | 14.65% | 6.19% | 89.16% |
| EPS Basic | 154.84% | -25.41% | -102.00% | 11.84% | 120.47% |
| Normalized Basic EPS | 1,738.96% | 25.32% | -95.01% | 4.82% | 102.55% |
| EPS Diluted | 150.00% | -25.41% | -102.06% | 11.84% | 120.41% |
| Normalized Diluted EPS | 1,733.78% | 25.32% | -94.73% | 4.82% | 102.45% |
| Average Basic Shares Outstanding | 1.33% | 0.84% | 0.76% | 0.56% | 0.42% |
| Average Diluted Shares Outstanding | 1.90% | 0.84% | -4.55% | 0.56% | 4.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |